共 11 条
[3]
Prescript-assist? probiotic-prebiotic treatment for irritable bowel syndrome: An open-label, partially controlled, 1-year extension of a previously published controlled clinical trial[J] . Alvah C. Bittner,Robert M. Croffut,Mary C. Stranahan,Titut N. Yokelson.Clinical Therapeutics . 2007 (6)
[6]
Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion That Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study[J] . Mark Pimentel,Soumya Chatterjee,Evelyn J. Chow,Sandy Park,Yuthana Kong.Digestive Diseases and Sciences . 2006 (8)
[7]
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles[J] . Liam O’Mahony,Jane McCarthy,Peter Kelly,George Hurley,Fangyi Luo,Kersang Chen,Gerald C. O’Sullivan,Barry Kiely,J. Kevin Collins,Fergus Shanahan,Eamonn M.M. Quigley.Gastroenterology . 2005 (3)
[8]
The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome—a double blind, placebo-controlled, randomized study[J] . Eva Niv,Timna Naftali,Ron Hallak,Nachum Vaisman.Clinical Nutrition . 2005 (6)
[10]
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome[J] . Krzysztof Niedzielin,Hubert Kordecki,Bo? ena Birkenfeld.European Journal of Gastroenterology & Hepatology . 2001 (10)